Occurrence of lymphomas during ddC or ddC/zidovudine combination therapy in persons infected with HIV type 1.
Moyle
G J
GJ
D000998:Antiviral Agents / Q000009:adverse effects*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D008223:Lymphoma / Q000150:complications*; D016047:Zalcitabine / Q000009:adverse effects*; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D015215:Zidovudine; D016047:Zalcitabine